Durvalumab-associated generalized morphea with overlapping vitiligo

• Julianna Martel, MD,
• Woo Cheal Cho, MD,
• John S. Runge, PhD,
• Anisha B. Patel, MD,
• Jean Tayar, MD,
• Karin Woodman, MD,
• Celyne Bueno Hume, MD,
• Jonathan Curry, MD,
• Meghan Heberton, MD

Affiliations

Julianna Martel, MD

Department of Dermatology, University of Texas Medical School at Houston, Houston, Texas

Woo Cheal Cho, MD

Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas

John S. Runge, PhD

University of Michigan Medical School, Ann Arbor, Missouri

Anisha B. Patel, MD

Department of Dermatology, University of Texas Medical School at Houston, Houston, Texas; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Jean Tayar, MD

Department of Rheumatology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Karin Woodman, MD

Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Celyne Bueno Hume, MD

Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Jonathan Curry, MD

Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Meghan Heberton, MD

Correspondence to: Meghan Heberton, MD, Department of Dermatology, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390; Department of Dermatology, University of Texas Medical School at Houston, Houston, Texas; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; University of Michigan Medical School, Ann Arbor, Missouri; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Rheumatology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas